Related Experiment Video
Updated: Jan 3, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
The Cost-Effectiveness and Value Proposition of Brachytherapy
Charles C Vu1, Maha S Jawad1, Daniel J Krauss1
1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI.
Seminars in Radiation Oncology
|November 16, 2019
Summary
Brachytherapy, a cancer treatment, is underutilized despite its effectiveness. This review examines its cost-effectiveness for prostate, cervix, and endometrial cancers, suggesting a valuable role in oncology.
Area of Science:
- Oncology
- Radiation Therapy
Background:
- Brachytherapy is an effective cancer treatment.
- Utilization has declined for prostate and gynecologic cancers due to logistical, financial, and training issues.
- External beam radiation therapy is often preferred.
Purpose of the Study:
- To review analyses supporting brachytherapy's cost-effectiveness.
- To focus on prostate, cervix, and endometrial cancer management.
Main Methods:
- Review of existing analyses and literature.
- Focus on cost-effectiveness and treatment outcomes.
Main Results:
- Brachytherapy remains a cost-effective option for specific gynecologic and prostate cancers.
- Despite declining use, its value in certain oncologic settings is supported by data.
Conclusions:
- Brachytherapy is a cost-effective component of cancer management for prostate, cervix, and endometrial cancers.
- Addressing utilization barriers could restore brachytherapy's role in radiation oncology.
